SCHEDULE 13D - JUNIPER & IVY CORP

Company

AXIM BIOTECHNOLOGIES, INC.

Filed

September 23, 2022

Accession Number

0001096906-22-002326

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →